ckd glp 1 Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis GLP-1 therapy CKD - Diabetes

Cancer Sci (2021) 112:312535

This study aimed to explore the morbidity characteristics of SSIBs associated with GLP-1RAs by mining the FAERS database and measuring the association between GLP-1RAs and SSIBs through metrics such as time of onset, disproportionality analysis, and co-medication analysis

10.1210/er.2013-1121 96 TrujilloJ

The disruption of the HPG axis in PCOS and the possible beneficial effects of GLP-1 RA are depicted in Fig

L'analyse du taux de lipase Le dosage de la lipase, une enzyme qui permet la digestion des graisses, est un examen sanguin qui permet au mdecin de diagnostiquer une maladie du pancras